# Fosun International Receives "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal

- Link: https://www.thailand-business-news.com/pr-news/fosun-international-receives-esg-corporate-sustainability-excellence-award-from-hong-kong-economic-journal
- Published: 2026-11-06T08:00:00+07:00
- Author: PR Newswire

HONG KONG, Nov. 6, 2026 /PRNewswire/ — On 5 November 2026, _Hong Kong Economic Journal(
HKEJ)_, one of Hong Kong’s most influential Chinese financial publications, hosted
the "ESG & Sustainability Awards of Excellence 2026" ceremony. At the event, Fosun
International received the "ESG & Corporate Sustainability Excellence Award", recognizing
its remarkable achievements and strong market standing in advancing environmental,
social, and governance (ESG) practices as well as sustainability.

_HKEJ_ pointed out that the Government of the Hong Kong Special Administrative Region
officially released the _First Five-Year Plan for Economic and Social Development
of the Hong Kong Special Administrative Region (2026–2030)_ this year, setting out
a range of key green development and environmental protection targets. The government,
business community, financial institutions, and all sectors of society are working
together to advance Hong Kong’s green transition. Many well-known companies in Hong
Kong, including Fosun International, have long been committed to promoting ESG practices.
Their efforts hold significant strategic importance in reinforcing Hong Kong’s position
as an international financial center. The awards were established to recognize companies
that have made outstanding contributions to advancing sustainability. In addition
to Fosun International, other recipients of the awards include Henderson Land Development,
China Overseas Land & Investment, FWD Life Insurance, Bank of China (Hong Kong),
China Minsheng Bank Hong Kong Branch, etc.

**Advancing climate commitments to achieve notable recognition for ESG performance**

_HKEJ_ highlighted that global investors have attached increasing importance to 
the ESG performance of enterprises in recent years, while Fosun International has
continued to advance its ESG efforts, achieving remarkable results. To date, Fosun
International’s MSCI ESG Rating has been upgraded to the highest rating of AAA. 
It has been included in the _S&P Global Sustainability Yearbook 2026_ and also named
among the Top 1% in the _S&P Global Sustainability Yearbook (China Edition) 2026_
for the third consecutive year. Its Hang Seng Sustainability Rating has been upgraded
from AA- to AA+. It has also been selected as a constituent of the Hang Seng Corporate
Sustainability Benchmark Index for the seventh consecutive year and included as 
a constituent of the Hang Seng ESG 50 Index. Additionally, Fosun International’s
FTSE Russell ESG score has consistently been higher than the global industry average
and it has remained a constituent of the FTSE4Good Index Series for five consecutive
years.

To address climate change, Fosun actively responds to the national "dual carbon"
goals by promoting carbon neutrality and energy conservation and emission reduction.
In 2021, Fosun made a commitment to society – "strive to peak carbon emissions by
2028 and achieve carbon neutrality by 2050". Fosun has formulated strategies for
climate change mitigation and adaptation to align with the 1.5°C temperature control
target set in the _Paris Agreement_. In April 2026, Fosun International proactively
aligned with the Task Force on Climate-Related Financial Disclosures (TCFD) recommendations
and the _International Financial Reporting Standards S2 Climate-related Disclosures
Requirements (IFRS S2)_ by releasing its fourth Climate Information Disclosures 
Report, further enhancing the transparency of its climate initiatives and underscoring
its commitment to continuous progress in environmental stewardship.

**Leveraging innovation to deliver lasting social impact**

Fosun adheres to an innovation-driven strategy, continuously delivering innovative
achievements across its businesses to better serve society. Among which, Fosun’s
independently developed HANSIZHUANG became the world’s first and only anti-PD-1 
monoclonal antibody approved for the perioperative treatment of gastric cancer, 
pioneering a postoperative "chemo-sparing" regimen. HLX43, a core asset in the innovative
pipeline, is a potential best-in-class (BIC) broad-spectrum anti-tumor PD-L1 ADC.
It has demonstrated preliminary clinical efficacy characterized by high efficacy
and low toxicity across multiple solid tumors, including non-small cell lung cancer(
NSCLC), with over 1,500 patients enrolled globally. FUMAINING (luvoxmetinib tablets)
was approved for the treatment of pediatric and adolescent patients with relapsed
or refractory Langerhans cell histiocytosis (LCH), continuing to fill the gap in
the treatment of rare diseases.

Fosun remains committed to global cooperation and shared success, striving to make
medical technologies more accessible and affordable to more patients. Yi Kai Da,
China’s first CAR-T cell therapy product, has been used to treat more than 1,500
patients to date, while the marketing application of Fosun’s second CAR-T product,
brexucabtagene autoleucel, has been accepted for review. The first da Vinci 5, the
next-generation surgical system, was installed in Hong Kong SAR, and has been admitted
into the Special Review Procedure for Innovative Medical Devices by the National
Medical Products Administration (NMPA). The Ion Robotic Bronchoscopy (Ion System)
has been successfully approved for launch and commercialization in Chinese mainland.

In global public health, as of 30 June 2026, Fosun Pharma had cumulatively supplied
more than 460 million vials of artesunate for injection worldwide, saving more than
92 million patients with severe malaria.

**Committed to business for good, actively giving back to society**

In order to better promote the fulfillment and implementation of corporate social
responsibility, Fosun Foundation was established in 2012. It has been making unremitting
efforts in areas such as global emergency relief, rural revitalization, health, 
education, culture and art, youth development, to create social value. Of which,
since its launch at the end of 2017, Fosun Foundation’s Rural Doctors Program has
covered 78 counties in 16 provinces, cities, and autonomous regions, supporting 
25,000 rural doctors and benefiting 3 million rural families.

In support of youth entrepreneurship and development, Fosun and Fosun Foundation,
together with Portuguese insurance group Fidelidade and Portugal’s healthcare group
Luz Saúde (Peruvian insurer La Positiva joined in 2026), launched the Protechting
Open Innovation Program in early 2016. On 16 September this year, the first stop
of the China Roadshow Series for the eighth edition of the Protechting Open Innovation
Program (Protechting 8.0), was held at Hong Kong Science Park. Ten innovation and
technology teams from Portugal, Denmark, Brazil and beyond presented their innovations,
marking the highest number of participating teams since the program’s inception.
As of now, Protechting has engaged young entrepreneurs from more than 50 countries
and regions, facilitated the incubation of over 50 pilot projects, and supported
several youth-led ventures in scaling up.

Looking ahead, Fosun will continue to strengthen its core operations, drive innovation,
and deepen its globalization strategy. By joining hands with customers, partners,
investors, and society, Fosun remains steadfast in its original aspiration of "Contribution
to Society", actively advancing global ESG sustainability to fulfill its mission
of "Creating happier lives for families worldwide".

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Fosun International Receives "ESG & Corporate Sustainability Excellence Award" from Hong Kong Economic Journal ](https://www.prnasia.com/story/archive/5089879_AE89879_0?rand=184833)
